en ع
Back to main menu

About us

Who We Are

Learn about our mission, our charter and principles, and who we are.

Learn more
How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
MSF Association

Our staff “own” and manage MSF, making sure that we stay true to our mission and principles, through the MSF Associations.

GO TO SITE
Access Campaign

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
Patient blogs

Hear directly from the inspirational people we help as they talk about their experiences dealing with often neglected, life-threatening diseases.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Southern Africa Medical Unit

SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Manson Unit

The Manson Unit is a London, UK-based team of medical specialists who provide medical and technical support, and conduct research for MSF.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
War in Gaza:: find out how we're responding
Learn more
78 Results For "chagas"
 
msf-placeholder
Kala azar

Drugs for Neglected Diseases Initiative (DNDi): matching needs and opportunities

Neglected diseases such as leishmaniasis, trypanosomiasis, Chagas disease and malaria have a devastating impact on the world's poor. Project Update - 2 Jul 2004
 
msf-placeholder
Malaria

Malaria patients enter DNDi clinical trials

To ensure a balanced portfolio of drugs in the pipeline, DNDi mixes quick-fix with long-term projects. In the short term, DNDi is developing "fixed-dose" combinations (two drugs combined into one tablet) for uncomplicated malaria: artesunate/amodiaquine for use in Africa and artesunate/mefloquine for use in Asia and Latin America. Press Release - 2 Jul 2004
 
msf-placeholder
Bolivia

Bolivia's bug killers: Preventing the spread of Chagas

This bug spreads Chagas disease - endemic to Central and South America. There is treatment but it is not a vaccine. Once cured of an infection, a second can arrive the same day. The bug thrives in the straw and mud homes that are commonplace in rural areas. The disease may not take hold for up to 15 years after infection and can be fatal. Project Update - 18 Feb 2004
 
msf-placeholder
Bolivia

MSF calls upon Latin American governments to guarantee access to medicines in the continent

The XIII Iberoamerican Summit is an important forum for governments of the Americas to publicly express their commitment to the protection of public health. Press Release - 13 Nov 2003
 
msf-placeholder
Bolivia

A new calm follows protests in Bolivian capital

There were over 135 injured in the Miraflores Hospital, where MSF was present. Other hospitals in the city were also dealing with the injured, with the numbers straining the facilities and leaving many without materials or medicines. Project Update - 23 Oct 2003
 
msf-placeholder
DNDi

World's first nonprofit drug company launched

This article first appeared in CMAJ (Canadian Medical Association Journal), September 16, 2003. In the Media - 16 Sep 2003
 
msf-placeholder
Guatemala

Congressional decree in Guatemala hinders access to medicines

The decree bans the drug regulatory agency from using an originators' product data - which is necessary when giving the equivalent generic version approval. Press Release - 14 Jul 2003
 
msf-placeholder
DNDi

Aid agency launches latest initiative to tackle diseases in the developing world

Public health experts estimate that just 10% of worldwide funding of pharmaceutical research goes into infectious diseases that affect the world's poor people. Project Update - 5 Jul 2003
 
msf-placeholder
Chagas disease

Health bodies launch research push to find cures for unfashionable diseases

The World Health Organization estimates that between 300,000 and 500,000 people in 36 African countries suffer from sleeping sickness, which is carried by the tsetse fly. About 80 percent die before being diagnosed as the parasites enter their brains. Chagas Disease is a similar condition, carried by blood-sucking insects, that affects primarily Latin America. Project Update - 4 Jul 2003
 
msf-placeholder
DNDi

Neglected diseases kill poor

Diseases that kill millions of poor people every year are ignored by Western firms because drugs to combat them make no money, a new research body said as it was launched on Thursday. Project Update - 4 Jul 2003
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more